Clinical significance of HER2 overexpression as assessed by immunohistochemistry and fluorescence in situ hybridisation in patients with gastric cancer

被引：0
|
作者：
Im, S. [1 ]
Kim, J. [1 ]
Kim, M. [1 ]
Jordan, B. [2 ]
Oh, D. [1 ]
Lee, H. [1 ]
Yang, H. [1 ]
Kim, V [1 ]
Kim, W. [1 ]
Bang, Y. [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea
[2] Roche Diagnost Ltd, Rotkreuz, Switzerland
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [41] Characterisation of HER2 Status in DCIS Using Immunohistochemistry (IHC) and Chromogenic in situ Hybridisation (CISH)
    Miligy, I.
    Gaber, A.
    Toss, M. S.
    Al-Kawaz, A. A.
    Nolan, C. C.
    Diez-Rodriguez, M. A.
    Burrell, H.
    Ellis, I. O.
    Green, A. R.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2018, 245 : S5 - S5
  • [42] Prognostic implication of HER2 overexpression in surgically treated patients with gastric cancer
    Enkhbat, E.
    Munkhjargal, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S119 - S119
  • [43] Clinical significance of Her2/neu overexpression in urothelial carcinomas
    Alexa, Aurora
    Baderca, Flavia
    Zahoi, Delia Elena
    Lighezan, Rodica
    Izvernariu, D.
    Raica, M.
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2010, 51 (02): : 277 - 282
  • [44] Comparison of immunohistochemistry and fluorescence in situ hybridisation techniques for determination of the HER2 gene status of patients with metastatic breast cancer in France:: final results of the FISH 2002 study.
    Penault-Llorca, F.
    Ettore, F.
    Antoine, M.
    Fermeaux, V
    Lacroix-Triki, M.
    Gosset, P.
    Sagan, C.
    Escourrou, G.
    Vincent-Salomon, A.
    Lannes, B.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S218 - S218
  • [45] Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature
    Liang, Ji-wang
    Zhang, Jian-jun
    Zhang, Tao
    Zheng, Zhi-chao
    TUMOR BIOLOGY, 2014, 35 (05) : 4849 - 4858
  • [46] HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods
    Bartlett, J. M. S.
    Starczynski, J.
    Atkey, Neil
    Kay, E.
    O'Grady, A.
    Gandy, Michael
    Ibrahim, Merdol
    Jasani, Bharat
    Ellis, I. O.
    Pinder, S. E.
    Walker, R. A.
    JOURNAL OF CLINICAL PATHOLOGY, 2011, 64 (08) : 649 - 653
  • [47] Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: Comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH)
    Kiyose, Shinichiro
    Igarashi, Hisaki
    Nagura, Kiyoko
    Kamo, Takaharu
    Kawane, Kazunori
    Mori, Hiroki
    Ozawa, Takachika
    Maeda, Matsuyoshi
    Konno, Keisuke
    Hoshino, Hideaki
    Konno, Hiroyuki
    Ogura, Hiroyuki
    Shinmura, Kazuya
    Hattori, Naohiko
    Sugimura, Haruhiko
    PATHOLOGY INTERNATIONAL, 2012, 62 (11) : 728 - 734
  • [48] HER-2 analysis in tissue microarrays of archival human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridisation
    Flahavan, C
    O'Grady, A
    Barrett, H
    Leader, M
    Kay, E
    JOURNAL OF PATHOLOGY, 2002, 198 : 7A - 7A
  • [49] Evaluation of HER2/neu status by immunohistochemistry and correlation with gene amplification by fluorescence in situ hybridisation assay in rare breast carcinoma case
    Terzi, N. Kaya
    Kucukodaci, Z.
    VIRCHOWS ARCHIV, 2018, 473 : S210 - S210
  • [50] A meta-analysis on concordance between immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) to detect HER2 gene overexpression in breast cancer
    Bahreini, Fatemeh
    Soltanian, Ali Reza
    Mehdipour, Parvin
    BREAST CANCER, 2015, 22 (06) : 615 - 625
12345